Operating and investment executive focused on growth-stage technology and healthcare opportunities, Robin Gould combines operating leadership with private equity and venture experience across product, commercial strategy and M&A. Known for scaling teams, driving go-to-market expansion and executing strategic exits, she works with boards and management on capital raises, operational transformation and portfolio value creation. Fluent in cross-border transactions and C-suite advisory.
Operating and investment executive focused on growth-stage technology and healthcare opportunities, Robin Gould combines operating leadership with private equity and venture experience across product, commercial strategy and M&A. Known for scaling teams, driving go-to-market expansion and executing strategic exits, she works with boards and management on capital raises, operational transformation and portfolio value creation. Fluent in cross-border transactions and C-suite advisory.
Grows venture and growth-stage tech and healthcare businesses through hands-on operational investing, prioritizing companies with product-market fit and scalable go-to-market motion. Capital allocation favors follow-on support and structured growth rounds tied to performance milestones. Emphasizes operator-led value creation, rigorous commercial KPIs, cross-border M&A optionality and board-level governance to accelerate exits over a medium-term horizon while preserving downside through active portfolio oversight.
Grows venture and growth-stage tech and healthcare businesses through hands-on operational investing, prioritizing companies with product-market fit and scalable go-to-market motion. Capital allocation favors follow-on support and structured growth rounds tied to performance milestones. Emphasizes operator-led value creation, rigorous commercial KPIs, cross-border M&A optionality and board-level governance to accelerate exits over a medium-term horizon while preserving downside through active portfolio oversight.
| Trades 940 | Longs Won 682/940 72% | Profit Factor 38.7 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $585,636.21 |
| Average Win $110,136.22 | Best Trade (Aug 14) $13.24M | Sharpe Ratio -9.54 |
| Average Loss -$7,523.23 | Worst Trade (Sep 01) -$326,089.4 | Z-Score 5.83 (100%) |
| Commissions $0 | Avg. Trade Length 1y 4m 3w 2d | Expectancy $77,842.45 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 33,333 | 30,000 | 26,667 | 23,333 | 20,000 | 16,667 | 13,333 | 10,000 | 6,667 | 3,333 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 11,810 | $2.35M | $3.65M | - | $1.3M | 55.13% | -7.354% |
ABBV AbbVie Inc. | 2,075 | $359,526.52 | $520,700.5 | - | $161,173.98 | 44.83% | -2.513% |
ABT Abbott Laboratories | 2,647 | $291,985.6 | $279,787.9 | - | -$12,197.7 | -4.18% | +0.085% |
AGG iShares Core U.S. Aggregate Bond ETF | 24,905 | $2.47M | $2.42M | - | -$41,339.01 | -1.68% | -0.256% |
AMAT Applied Materials, Inc. | 683 | $233,528 | $346,738.62 | - | $113,210.62 | 48.48% | +1.176% |
AMD Advanced Micro Devices, Inc. | 1,624 | $232,435 | $773,267.58 | - | $540,832.58 | 232.68% | -1.904% |
AMZN Amazon.com Inc | 4,247 | $702,527.46 | $1.15M | - | $450,872.76 | 64.18% | +15.321% |
ANGL VanEck Fallen Angel High Yield Bond ETF | 19,276 | $554,755.44 | $557,461.92 | - | $2,706.48 | 0.49% | -0.035% |
BND Vanguard Total Bond Market Index Fund | 15,250 | $1.12M | $1.1M | - | -$22,999.75 | -2.05% | -0.262% |
BNDX Vanguard Total International Bond ETF | 10,364 | $509,787.58 | $495,088.28 | - | -$14,699.3 | -2.88% | -0.23% |
BRK-B Berkshire Hathaway Inc. | 1,378 | $590,005.34 | $704,902.12 | - | $114,896.78 | 19.47% | +0.365% |
CAT Caterpillar Inc. | 350 | $200,505 | $285,183.5 | - | $84,678.5 | 42.23% | +0.701% |
COST Costco Wholesale Corporation | 489 | $331,186.3 | $465,474.21 | - | $134,287.91 | 40.55% | -0.239% |
EFA iShares MSCI EAFE ETF | 2,050 | $212,967 | $216,439 | - | $3,472 | 1.63% | -0.621% |
EFAV iShares MSCI EAFE Min Vol Factor ETF | 2,548 | $199,329.41 | $236,811.12 | - | $37,481.71 | 18.8% | -1.086% |
EWC iShares MSCI Canada ETF | 4,426 | $162,347.77 | $262,860.14 | - | $100,512.37 | 61.91% | -0.669% |
FXH First Trust Health Care AlphaDEX Fund | 2,547 | $263,840.21 | $323,672.77 | - | $59,832.56 | 22.68% | -0.703% |
GLD SPDR Gold Shares | 3,370 | $647,259.32 | $1.25M | - | $604,830.51 | 93.44% | -1.49% |
GME Gamestop Corp. | 33,673 | $637,978.5 | $731,377.56 | - | $93,399.06 | 14.64% | -0.731% |
GOOGL Alphabet Inc | 1,240 | $181,511.71 | $441,601.2 | - | $260,089.49 | 143.29% | +6.734% |